Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
US7598288B2 · kind B2 · utility
14Cited by
7References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 2002 |
| Grant date | Oct 6, 2009 |
| Priority date | — |
| Expiry date | Dec 7, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of inhibitors of GSK-3 useful for treating glaucoma is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.